hylander, I agree. Emily was a bit nervous. I cam
Post# of 36537
(Total Views: 236)
Posted On: 10/15/2019 1:09:31 PM
hylander,
Yes, I think he may have to move the 1:1 dividend and you know the naysayers will jump on this, but it is the right move. Also, in our opinion, the NGIO should double or triple the market cap of GNBT, however on the OTC with no analyst coverage and institutional, that is not a guarantee. So if we get on the NASDAQ before the end of Nov, before NGIO, then we could see a big move.
I was the caller he was talking to when he made that comment. He didn't say how much they were getting, nor the terms.
Quote:NOPE! lol
I agree. Emily was a bit nervous. I came in right after her and tried to clarify what she was stating. Not sure if I did a good job or not.
Quote:
I think the 1:1 would be better off moving after the uplist in any case to benefit from the move and to improve the chances for the uplist.
With the NGIO happening at the end of November it looks like, that is a big point as that helps the stock as well I think.
Yes, I think he may have to move the 1:1 dividend and you know the naysayers will jump on this, but it is the right move. Also, in our opinion, the NGIO should double or triple the market cap of GNBT, however on the OTC with no analyst coverage and institutional, that is not a guarantee. So if we get on the NASDAQ before the end of Nov, before NGIO, then we could see a big move.
Quote:
Not sure if anyone caught the statement that Joe said about the loan also.
I was the caller he was talking to when he made that comment. He didn't say how much they were getting, nor the terms.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼